Summary
Teradyne, Inc.'s 2004 Form 10-K highlights a significant turnaround from the previous year, marked by a substantial increase in net revenue and a return to profitability. The Semiconductor Test Systems segment was the primary growth driver, benefiting from strong demand in the System-on-a-Chip (SOC) market, particularly from Asian sub-contractors and fabless companies. This segment now represents the largest portion of Teradyne's revenue. The company has also seen a healthy increase in its Connection Systems segment, driven by demand in networking and telecommunications. Operationally, Teradyne has made strides in improving its gross margin through increased sales volumes, a favorable product mix, and cost reductions stemming from prior restructuring efforts. The company has been managing its expenses diligently, with notable reductions in R&D and SG&A as a percentage of revenue compared to prior years. Despite a challenging market environment in previous years that led to significant restructuring charges and goodwill impairment, Teradyne has positioned itself for future growth by investing in new product development, such as the FLEX test system. Financially, Teradyne has improved its liquidity, with a significant increase in cash, cash equivalents, and marketable securities. The company's long-term debt has decreased, and it continues to manage its convertible senior notes. Investors should note the company's ongoing commitment to research and development, which is crucial for maintaining its competitive edge in the rapidly evolving semiconductor and electronics industries. The company currently does not pay dividends, reinvesting earnings for growth.
Key Highlights
- 1Teradyne reported a strong financial performance in 2004, with net revenue increasing by 32% to $1.79 billion, a significant rebound from the previous year.
- 2The Semiconductor Test Systems segment was the dominant growth driver, with revenue up 56% to $1.15 billion, representing 64% of total net revenue.
- 3The company returned to profitability in 2004, with net income of $165.2 million, a substantial improvement from a net loss of $194.0 million in 2003.
- 4Gross margin improved significantly to 40.4% in 2004 from 29.5% in 2003, driven by higher sales volumes, improved product mix, and cost efficiencies from prior restructuring.
- 5Teradyne continued to invest heavily in research and development, with $262.0 million spent in 2004, though this represented a lower percentage of revenue (14.6%) compared to prior years.
- 6The company's backlog decreased by approximately 19.5% to $407.2 million at the end of 2004 compared to $506.1 million at the end of 2003, indicating a potential slowdown in order intake towards year-end.
- 7Teradyne maintained a strong liquidity position, with cash, cash equivalents, and marketable securities totaling $482.0 million at December 31, 2004.